Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Summary

The purpose of this study is to evaluate the safety and efficacy of High Dose-Rate Brachytherapy in patients with both primary and secondary liver malignancies.

General Information

NCT#: NCT05053555
Study ID: 2020-1255
Trial Phase: Phase I

Trial Sponsor: M.D. Anderson Cancer Center
Therapies Used in This Trial: High dose rate brachytherapy

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search